Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Guardant Health Inc
(NQ:
GH
)
27.68
-0.70 (-2.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Guardant Health Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 27, 2024
Via
Benzinga
Evaluating Guardant Health: Insights From 5 Financial Analysts
May 24, 2024
Via
Benzinga
Deckers Outdoor Posts Upbeat Earnings, Joins Guardant Health, Ross Stores And Other Big Stocks Moving Higher On Friday
May 24, 2024
Via
Benzinga
FDA Advisory Panel Supports Approval Of Guardant Health's Blood Test For Colorectal Cancer Screening
May 24, 2024
FDA panel recommends approval for Guardant Health's Shield blood test for colorectal cancer screening.
Via
Benzinga
Exposures
Product Safety
Guardant Health Rockets After FDA Panel Recommends Approval For Blood-Based Colon Cancer Test
May 24, 2024
The companies are likely to soon battle it out in the colon cancer screening market.
Via
Investor's Business Daily
Exposures
Product Safety
Key Takeaways From Guardant Health Analyst Ratings
April 24, 2024
Via
Benzinga
Analyst Expectations For Guardant Health's Future
April 05, 2024
Via
Benzinga
FDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option
May 23, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer Screening
May 23, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in Upcoming Investor Conferences
May 22, 2024
From
Guardant Health, Inc.
Via
Business Wire
What's Going On With Colorectal Cancer Diagnostic-Focused Guardant Health Stock On Tuesday?
May 21, 2024
FDA staff reviewers raise concerns over Guardant Health's experimental Shield blood test for colorectal cancer, citing low sensitivity in detecting certain tumor types. Shield aims to improve early CRC...
Via
Benzinga
Exposures
Product Safety
Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications
May 21, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease Week
May 16, 2024
From
Guardant Health, Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
May 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 10, 2024
Via
Benzinga
GH Stock Earnings: Guardant Health Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
GH stock results show that Guardant Health beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
May 09, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in Upcoming Investor Conferences
May 07, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Surpasses 500 Peer-Reviewed Publications Milestone
May 07, 2024
From
Guardant Health, Inc.
Via
Business Wire
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
April 22, 2024
Via
Benzinga
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
April 22, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
April 18, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
April 03, 2024
From
Guardant Health, Inc.
Via
Business Wire
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
April 02, 2024
The companies are working to detect colon cancer and precancerous markers in blood and/or stool.
Via
Investor's Business Daily
Better Than ChatGPT? New Super AI Bot Says Buy These 3 Stocks.
April 01, 2024
These stocks are solid buys according to the advanced AI model Claude 3, which has been touted as potentially superior to ChatGPT.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
March 28, 2024
U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat...
Via
Benzinga
Insiders Buying Advance Auto Parts And 2 Other Stocks
March 20, 2024
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.
Via
Benzinga
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
March 13, 2024
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 06, 2024
From
Guardant Health, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.